Intra-Cellular Therapies, Inc. (ITCI)
NASDAQ: ITCI · Real-Time Price · USD
128.60
+0.06 (0.05%)
Feb 21, 2025, 4:00 PM EST - Market closed
Intra-Cellular Therapies Market Cap
Intra-Cellular Therapies has a market cap or net worth of $13.66 billion as of February 21, 2025. Its market cap has increased by 105.75% in one year.
Market Cap
13.66B
Enterprise Value
12.68B
1-Year Change
105.75%
Ranking
Category
Stock Price
$128.60
Market Cap Chart
Since January 7, 2014, Intra-Cellular Therapies's market cap has increased from $332.00M to $13.66B, an increase of 4,015.34%. That is a compound annual growth rate of 39.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 13.63B | 53.90% |
| Dec 31, 2024 | 8.85B | 28.46% |
| Dec 29, 2023 | 6.89B | 37.53% |
| Dec 30, 2022 | 5.01B | 17.54% |
| Dec 31, 2021 | 4.26B | 67.27% |
| Dec 31, 2020 | 2.55B | 34.44% |
| Dec 31, 2019 | 1.90B | 204.19% |
| Dec 31, 2018 | 623.30M | -21.13% |
| Dec 29, 2017 | 790.30M | 21.04% |
| Dec 30, 2016 | 652.90M | -71.79% |
| Dec 31, 2015 | 2.31B | 345.98% |
| Dec 31, 2014 | 518.90M | 56.30% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 782.81B |
| UnitedHealth Group | 462.12B |
| Johnson & Johnson | 379.66B |
| Novo Nordisk | 365.53B |
| AbbVie | 348.30B |
| AstraZeneca | 230.61B |
| Abbott Laboratories | 228.41B |
| Intuitive Surgical | 216.02B |